Skip to main content


Figure 2 | AIDS Research and Therapy

Figure 2

From: HIV-1 mutational pathways under multidrug therapy

Figure 2

Frequency of common mutations. The percentage of therapies which developed mutation during therapy at the indicated location (top), and which had a preexisting mutation at the indicated location (bottom), by risk group. The patterns are consistent across the different risk groups. Locations are codons which were mutant at the start of 5% or more of the therapies, but which are not included on the International AIDS Society list of resistance mutations [18].

Back to article page